Quote:
Originally Posted by jeffreyn
I think an "abstract" is all we are likely to get for quite a while yet. As it says in the PNT article, the Georgetown Phase 2 trial is still ongoing.
|
If the present trials show continued safety and success will this drug get fast track status as a breakthrough therapy? Indications so far sure suggest that it qualifies!
https://www.fda.gov/forpatients/appr...st/default.htm